<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">and </span>
   <span class="font14">for </span>
   <span class="font13">clinical </span>
   <span class="font13">treatment </span>
   <span class="font13">with </span>
   <span class="font13">were </span>
   <span class="font13">domain </span>
   <span class="font12">from </span>
   <span class="font12">ACSS </span>
   <span class="font12">patients </span>
   <span class="font12">The </span>
   <span class="font12">was </span>
   <span class="font12">symptoms </span>
   <span class="font12">fees </span>
   <span class="font12">personal </span>
   <span class="font11">{background </span>
   <span class="font11">assessment </span>
   <span class="font11">overall </span>
   <span class="font11">visit </span>
   <span class="font11">Symptom </span>
   <span class="font11">â‰¤condition </span>
   <span class="font11">typical </span>
   <span class="font11">Acute </span>
   <span class="font11">Cystitis </span>
   <span class="font11">trial </span>
   <span class="font11">Typical </span>
   <span class="font11">[]. </span>
   <span class="font11">are </span>
   <span class="font11">margin </span>
   <span class="font11">outcome </span>
   <span class="font11">BNO </span>
   <span class="font11">analysis </span>
   <span class="font11">not </span>
   <span class="font11">{border-style </span>
   <span class="font11">Score </span>
   <span class="font11">day </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Supplementary </span>
   <span class="font11">patient-reported </span>
   <span class="font11">thresholds </span>
   <span class="font11">tract </span>
   <span class="font11">urinary </span>
   <span class="font11">used </span>
   <span class="font11">Table </span>
   <span class="font11">efficacy </span>
   <span class="font11">uncomplicated </span>
   <span class="font11">patient </span>
   <span class="font10">Drug </span>
   <span class="font10">Fig. </span>
   <span class="font10">all </span>
   <span class="font10">full </span>
   <span class="font10">measure </span>
   <span class="font10">which </span>
   <span class="font10">LINK </span>
   <span class="font10">compared </span>
   <span class="font10">investigator </span>
   <span class="font10">(BNO </span>
   <span class="font10">acute </span>
   <span class="font10">other </span>
   <span class="font10">item </span>
   <span class="font10">questionnaire </span>
   <span class="font10">that </span>
   <span class="font10">â€œclinical </span>
   <span class="font10">.%, </span>
   <span class="font10">European </span>
   <span class="font10">Food </span>
   <span class="font10">Medicines </span>
   <span class="font10">U.S. </span>
   <span class="font10">criteria </span>
   <span class="font10">group </span>
   <span class="font10">guidelines </span>
   <span class="font10">results </span>
   <span class="font10">Part </span>
   <span class="font10">QoL </span>
   <span class="font10">antibacterial </span>
   <span class="font10">cureâ€� </span>
   <span class="font10">defining </span>
   <span class="font10">dynamics </span>
   <span class="font10">follow-up </span>
   <span class="font10">has </span>
   <span class="font10">infections </span>
   <span class="font10">quality </span>
   <span class="font10">severity </span>
   <span class="font10">using </span>
   <span class="font10">Bionorica </span>
   <span class="font10">EMA </span>
   <span class="font10">FDA </span>
   <span class="font10">FDA, </span>
   <span class="font10">FT: </span>
   <span class="font10">QoL, </span>
   <span class="font10">also </span>
   <span class="font10">between </span>
   <span class="font10">but </span>
   <span class="font10">groups </span>
   <span class="font10">included </span>
   <span class="font10">phase </span>
   <span class="font10">px; </span>
   <span class="font10">questions </span>
   <span class="font10">relation </span>
   <span class="font10">this </span>
   <span class="font10">three </span>
   <span class="font10">women </span>
   <span class="font10">{font-family </span>
   <span class="font10">(Supplementary </span>
   <span class="font10">(n=) </span>
   <span class="font10">Administration; </span>
   <span class="font10">EMA, </span>
   <span class="font10">III </span>
   <span class="font10">Int </span>
   <span class="font10">Urol </span>
   <span class="font10">considered </span>
   <span class="font10">data </span>
   <span class="font10">diagnosis </span>
   <span class="font10">different </span>
   <span class="font10">end </span>
   <span class="font10">font-size </span>
   <span class="font10">fosfomycin </span>
   <span class="font10">lower </span>
   <span class="font10">medicinal </span>
   <span class="font10">only </span>
   <span class="font10">randomized, </span>
   <span class="font10">set </span>
   <span class="font10">studies </span>
   <span class="font10">such </span>
   <span class="font10">validated </span>
   <span class="font10">(ROC)-curves: </span>
   <span class="font10">(adapted </span>
   <span class="font10">Agency. </span>
   <span class="font10">Andre </span>
   <span class="font10">For </span>
   <span class="font10">Kurt </span>
   <span class="font10">Receiver </span>
   <span class="font10">UTI </span>
   <span class="font10">additional </span>
   <span class="font10">antibiotics </span>
   <span class="font10">bacteriuria </span>
   <span class="font10">blood </span>
   <span class="font10">can </span>
   <span class="font10">characteristic </span>
   <span class="font10">comparing </span>
   <span class="font10">diagnostics </span>
   <span class="font10">double-blind, </span>
   <span class="font10">double; </span>
   <span class="font10">life; </span>
   <span class="font10">main </span>
   <span class="font10">nonantibacterial </span>
   <span class="font10">noninferiority </span>
   <span class="font10">number </span>
   <span class="font10">operating </span>
   <span class="font10">performed </span>
   <span class="font10">predefined </span>
   <span class="font10">several </span>
   <span class="font10">symptoms, </span>
   <span class="font10">therapy </span>
   <span class="font10">treated </span>
   <span class="font10">use </span>
   <span class="font10">visible </span>
   <span class="font10">visits </span>
   <span class="font10">â‰¤, </span>
   <span class="font10">&amp;gt;; </span>
   <span class="font10">(.%), </span>
   <span class="font10">(symptoms </span>
   <span class="font10">(visit </span>
   <span class="font10">Clinical </span>
   <span class="font10">Dimitri </span>
   <span class="font10">FT, </span>
   <span class="font10">Health </span>
   <span class="font10">Hubert </span>
   <span class="font10">Jakhongir </span>
   <span class="font10">Martina </span>
   <span class="font10">Overesch, </span>
   <span class="font10">Research </span>
   <span class="font10">[], </span>
   <span class="font10">al.The </span>
   <span class="font10">been </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">comparable </span>
   <span class="font10">could </span>
   <span class="font10">cure </span>
   <span class="font10">cystitis </span>
   <span class="font10">days </span>
   <span class="font10">define </span>
   <span class="font10">evaluated </span>
   <span class="font10">female </span>
   <span class="font10">frequency, </span>
   <span class="font10">investigational </span>
   <span class="font10">may </span>
   <span class="font10">outcomes </span>
   <span class="font10">percentages </span>
   <span class="font10">positive </span>
   <span class="font10">reported </span>
   <span class="font10">set. </span>
   <span class="font10">solid; </span>
   <span class="font10">start </span>
   <span class="font10">study </span>
   <span class="font10">test </span>
   <span class="font10">versus </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(.%) </span>
   <span class="font10">(ACSS) </span>
   <span class="font10">(n, </span>
   <span class="font10">-point </span>
   <span class="font10">.Â±.; </span>
   <span class="font10">ACSS-typical </span>
   <span class="font10">Abramov-Sommariva, </span>
   <span class="font10">Assessment </span>
   <span class="font10">Center </span>
   <span class="font10">Criterion </span>
   <span class="font10">Department </span>
   <span class="font10">Florian </span>
   <span class="font10">Hoeller, </span>
   <span class="font10">Patients </span>
   <span class="font10">This </span>
   <span class="font10">activities </span>
   <span class="font10">antibiotic </span>
   <span class="font10">any </span>
   <span class="font10">approved </span>
   <span class="font10">authors. </span>
   <span class="font10">based </span>
   <span class="font10">bold </span>
   <span class="font10">condition </span>
   <span class="font10">courier; </span>
   <span class="font10">development </span>
   <span class="font10">differential </span>
   <span class="font10">domain), </span>
   <span class="font10">em; </span>
   <span class="font10">following </span>
   <span class="font10">found </span>
   <span class="font10">fulfilled </span>
   <span class="font10">herbal </span>
   <span class="font10">hoc </span>
   <span class="font10">impact </span>
   <span class="font10">inclusion </span>
   <span class="font10">indicated </span>
   <span class="font10">infection </span>
   <span class="font10">life </span>
   <span class="font10">more </span>
   <span class="font10">multicenter, </span>
   <span class="font10">negative </span>
   <span class="font10">noninterventional </span>
   <span class="font10">pain </span>
   <span class="font10">parallel-group, </span>
   <span class="font10">post </span>
   <span class="font10">potential </span>
   <span class="font10">pt;} </span>
   <span class="font10">questionnaire, </span>
   <span class="font10">randomly </span>
   <span class="font10">rated </span>
   <span class="font10">score </span>
   <span class="font10">scoring </span>
   <span class="font10">shows </span>
   <span class="font10">suitable </span>
   <span class="font10">sum </span>
   <span class="font10">sum-scores </span>
   <span class="font10">than </span>
   <span class="font10">their </span>
   <span class="font10">treatment); </span>
   <span class="font10">trometamol. </span>
   <span class="font10">two </span>
   <span class="font10">uUTIs </span>
   <span class="font10">urgency, </span>
   <span class="font10">urine </span>
   <span class="font10">who </span>
   <span class="font10">â€" </span>
  </p>
 </body>
</html>
